Huangbing Wu
- Oncology top 10%
- Molecular Biology
- Surgery
- Pharmacology top 5%
- Cancer Research
- Co-authors
- Michele Yip-SchneiderC. Max SchmidtTsui‐Hwa TsengChunyu ChuErl‐Shyh KaoRosalie A. CarrPeter A. CrooksNarasimhan P. Agaram
- Topics
- Pancreatic and Hepatic Oncology Research (14 papers)Pancreatitis Pathology and Treatment (10 papers)Inflammatory mediators and NSAID effects (5 papers)
- Cited by
- PharmacologyBiochemistryOncology
- Partner nations
- United StatesTaiwanRussia
In The Last Decade
Huangbing Wu
25 papers receiving 642 citations
Peers
Comparison fields: 5 of 69
- Oncology 259
- Molecular Biology 223
- Surgery 170
- Pharmacology 140
- Cancer Research 134
Countries citing papers authored by Huangbing Wu
This map shows the geographic impact of Huangbing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huangbing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huangbing Wu more than expected).
Fields of papers citing papers by Huangbing Wu
This network shows the impact of papers produced by Huangbing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huangbing Wu. The network helps show where Huangbing Wu may publish in the future.
Co-authorship network of co-authors of Huangbing Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Huangbing Wu. A scholar is included among the top collaborators of Huangbing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huangbing Wu. Huangbing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 6 | |
| 4 | 15 | |
| 5 | 11 | |
| 6 | 11 | |
| 7 | 55 | |
| 8 | 29 | |
| 9 | 23 | |
| 10 | 36 | |
| 11 | 55 | |
| 12 | 21 | |
| 13 | 20 | |
| 14 | 25 | |
| 15 | 28 | |
| 16 | 26 | |
| 17 | 14 | |
| 18 | 14 | |
| 19 | 4 | |
| 20 | 190 |
About Huangbing Wu
Huangbing Wu is a scholar working on Oncology, Cancer Research and Hepatology, having authored 26 papers that have together received 677 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (14 papers), Pancreatitis Pathology and Treatment (10 papers) and Inflammatory mediators and NSAID effects (5 papers). The work is most often cited by research in Pharmacology (140 citations), Biochemistry (65 citations) and Oncology (259 citations). Huangbing Wu has collaborated with scholars based in United States, Taiwan and Russia. Frequent co-authors include Michele Yip-Schneider, C. Max Schmidt, Tsui‐Hwa Tseng, Chunyu Chu, Erl‐Shyh Kao, Rosalie A. Carr, Peter A. Crooks, Narasimhan P. Agaram, Max Schmidt and Milan Radovich. Their work appears in journals such as Hepatology, Cancer Letters and Food and Chemical Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.